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The publicity surrounding the first successful derivation of a
human embryonic stem (hES) cell line in 1998 raised the
expectation that stem cells will be the panacea for all diseases as
well as provoking an ethical debate with respect to the way in
which human embryos are used in research. ‘Human Embryonic
Stem Cells’ is the first book solely dedicated to this field, covering
all aspects of hES biology, providing a balanced discussion of
ethical issues, as well as a detailed description of the progress that
has been made in understanding how these cells function.
The book is arranged as a compilation of chapters, written by
experts in the field. The first three chapters deal with both the
ethical and policy issues, while the remaining 15 chapters describe
methods for HES cell isolation, their propagation and differentia-
tion, and the potential therapeutic application of this research.
There is enough breadth to be informative both to the novice as
well as established researchers in the field.
Human embryonic stem cells can only be isolated from the
blastocyst stage embryo and hence is an ethically contentious
issue. The first chapter of the book describes both sides of the
ethical debate, which is mainly centred on defining the point at
which life begins during development and balancing this against
the potential benefits that using surplus embryos could provide to
society. It explains the position of different religions and describes
the national policies that various countries have implemented to
regulate this research. The book also discusses the alternative
sources of stem cells (both pluripotent and adult cells), explaining
in this context the characteristics that make hES cells so unique. A
chapter is also dedicated to the controversial subject of therapeutic
cloning and provides a very balanced discussion of the ethical and
technical issues involved. Overall, the sections of the book dealing
with ethical issues are very well written and balanced, leaving the
reader to draw their own conclusions about the morality of hES
cell research.
For researchers in the US, there is a particularly useful chapter
written as a researcher’s guide to federally funded cell research in
the US. In August 2001, President Bush banned the derivation of
new human ES lines using public funds and restricted research to
existing hES line. This chapter explains succinctly what research is
allowed and prohibited with public funds, and also has an
important section explaining the restrictions that also apply to
research outside the US when performed in collaboration with US
researchers. A surprising point raised in this chapter is the fact
that embryo research performed with private money in the US is
basically unregulated. The book also has a section on patents that
infringe on hES cell research and has a great introduction to patent
law for the uninitiated. This is particularly relevant for researchers
who are interested in commercially exploiting hES cell technolo-
gies and explains how restrictive the original US patent is to the
development of hES-based therapies. The stance of the European
Patent office is also discussed and how its regulation is much
more flexible, opening up greater competition than is possible in
the US.
Only one chapter of the book is dedicated to detailed protocols
describing the methods for deriving hES cells and the complex
methods required for maintaining the cells in an undifferentiated
state. It is especially useful since the original publications
describing hES derivation contain very little methodological detail.
This is the only chapter of the book containing detailed protocols
and so anyone purchasing this book with the expectation that it
will contain detailed protocols covering all aspects of hES research
will be disappointed. Nevertheless, the book does contain five very
comprehensive chapters describing the approaches used by
different groups to differentiate hES cells to specific cell types.
These chapters are up to date and very well referenced, allowing
the reader to access easily the original research articles for the
methodological detail. The authors draw useful comparisons
between the signalling events that are known to occur in vivo
during early embryonic development and the attempts to recreate
these conditions in vitro. They also highlight the different
responses of mouse and human ES cells to similar differentiation
stimuli. When reading the book, one is struck by how much this
field is in its infancy, as demonstrated by the fact that many of the
chapters are based on only one or two publications describing the
initial attempts to differentiate human ES cells. This is due in
part to the limited number of labs that have had access to hES cell
lines since their isolation in 1998. This situation is rapidly
changing as the cell lines become more widely distributed around
the world.
The last section of the book deals with the potential therapeutic
development of hES cells. The clinical use of hES cells is still many
years away, particularly since we are yet to understand the
mechanisms that control the differentiation process. The authors
highlight the potential barriers to using hES cells for treating a
variety of diseases and discuss the various approaches being used
to resolve these problems. Such barriers include immune rejection,
uncontrolled proliferation and poor long-term survival of graft
tissue. This section of the book gives a clear outline of the FDA
regulations relevant to the development hES cell-based therapies
and presents a case study of a first clinical trails using human
neurone-like cell line derived from a human embryonic carcinoma
line for the treatment of stroke and spinal cord injury.
In summary, this is a very comprehensive text on all aspects of
hES cell biology. The book covers all of the latest developments in
the field, and is very timely due to the explosion of interested in
hES cells. As a consequence of the way the book has been
compiled, many topics are repeated throughout the text, but since
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different perspectives. As access to human ES cell lines becomes
more wide spread, this field will rapidly move forward and in a
very short span of time this book will become outdated. However,
this still remains the most comprehensive review of all aspects of
the hES cell biology, and is a must for anyone planning to break
into the field.
M Clements
Wellcome Trust Research Fellow, University College London, UK
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This multiauthor book on Ovarian Cancer edited by Ozols is a new
addition to the American Cancer Society Atlas of Clinical Oncology
series. As the name suggests, pictures and graphic illustrations are
prominent and it is this that sets the book apart from other
textbooks on ovarian cancer. The first two chapters on pathology
and biology use this technique well with numerous clear
illustrations of gross pathology and photomicrographs. The text
is reasonably comprehensive, although the pathology section
lacked information on the pattern of cytokeratin staining which
is frequently used to help distinguish ovarian cancers from other
malignant epithelial tumours involving the ovary. There is a strong
section on genetics that is well illustrated. However, in some
sections of the book the quality of graphic reproduction is poor.
There is a section on screening and counselling, but it did not
include ongoing screening research trials. There are generously
illustrated chapters on staging and surgical cytoreduction with a
text focusing on staging modalities and some of the controversies
surrounding the role of surgery.
Much of the second half of the book is devoted to therapy.
Chemotherapy is divided into chapters on primary chemotherapy,
developmental chemotherapy, including drug treatments at
relapse, and a chapter on high-dose chemotherapy. Recently
conducted clinical trials are discussed. References are reasonably
up to date, although some references to abstracts presented at the
American Society of Clinical Oncology meetings have now been
published as final papers. A whole chapter is devoted to high-dose
chemotherapy that is now only a relatively small component of
developmental chemotherapy. Also, the chapter refers almost
exclusively to the North American literature, with little mention of
the European data. The chapter on radiation therapy is very
detailed but clearly written. It provides a good reference to the field
but its emphasis in the book is rather greater than necessary;
nowadays radiation is used rather less frequently for the treatment
of ovarian cancer. Early stage management and palliative surgery
are two clinical areas dealt with in separate chapters. In the former,
the table of FIGO staging found in the chapter on staging is
repeated, which illustrates some of the difficulties in coordinating
a multiauthor text. Biological therapies are likely to become an
increasingly important component of ovarian cancer therapy and
the chapter on this is well written and illustrated. However, the
chief omission is any reference to inhibitors of EGFR or
angiogenesis. It is a pity that the chapters on germ cell and sex-
cord tumours appear as a ‘bolt on’. They are somewhat incomplete,
covering pathology and surgery with virtually nothing on
chemotherapeutic management.
The book is supplied with a CD Rom with full text and
illustrations (which is a little clumsy to run on an Apple
Macintosh). It is a useful accompaniment to the book that is
written from a North American perspective drawing mainly on the
writing of the world-renowned Fox Chase Cancer Centre, which
has extensive experience in the diagnosis and treatment of ovarian
cancer. The book is one of many on ovarian cancer. The main
criticism is that in some areas it falls in between a comprehensive
text and illustrated review. It will appeal mainly to a North
American readership and it is a useful addition to the library of
any clinical gynaecological oncologist.
JA Ledermann
University College London, UK
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